Michelle Elizabeth Yee

Title: Michelle Elizabeth Yee: Innovator in Viral Detection Technologies

Introduction

Michelle Elizabeth Yee is a prominent inventor based in San Jose, CA. She has made significant contributions to the field of viral detection, particularly in the context of respiratory viruses. Her work is crucial in the ongoing efforts to combat viral outbreaks and improve public health.

Latest Patents

Michelle holds a patent for "Compositions and methods for detecting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A and Influenza B." This patent describes methods for the rapid detection of the presence or absence of these viruses in biological or non-biological samples. The methods include performing an amplifying step, a hybridizing step, and a detecting step. Additionally, the patent provides primers and probes targeting SARS-CoV-2, influenza A, and influenza B, along with kits designed for their detection.

Career Highlights

Michelle is currently employed at Roche Molecular Systems, Inc., where she continues to innovate in the field of molecular diagnostics. Her work at Roche has positioned her as a key player in the development of technologies that enhance the detection of infectious diseases.

Collaborations

Michelle has collaborated with notable colleagues, including Chitra Manohar and Marcel Fontecha. These collaborations have further enriched her research and development efforts in viral detection technologies.

Conclusion

Michelle Elizabeth Yee's contributions to the field of viral detection are invaluable, particularly in the context of public health. Her innovative methods and dedication to research continue to make a significant impact in the fight against infectious diseases.